XBiotech (XBIT) Debt Ratio (2024)
XBiotech's (XBIT) Debt Ratio stood at 0.05 in Q4 2024, up 8.0% from the prior quarter.
Powered by 
Analysis
XBiotech (XBIT) Debt Ratio (2024) Analysis & Trends
Starting with Q1 2024, XBiotech's Debt Ratio history includes 4 quarters.
- Per Business Quant, the preceding three quarters came in at 0.05 (Q3 2024), 0.05 (Q2 2024) and 0.04 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 0.33 |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 0.23 |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 0.55 |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 0.41 |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -0.10 |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 0.56 |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 0.51 |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 0.31 |
| 10 | XBiotech | 58.23 Mn | -439.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.05 |
| Mar 31, 2024 | 0.04 |
API Access
XBiotech Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();